Abnormal Lung Aging in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis

被引:203
|
作者
Faner, Rosa [2 ,3 ]
Rojas, Mauricio [4 ]
MacNee, William [5 ]
Agusti, Alvar [1 ,2 ,3 ,6 ]
机构
[1] Univ Barcelona, Hosp Clin, Inst Torax, E-08036 Barcelona, Spain
[2] Fdn Invest Sanitaria Illes Balears, Ctr Invest Biomed Red Enfermedades Resp CIBERES, Palma De Mallorca, Spain
[3] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain
[4] Univ Pittsburgh, Sch Med, Dorothy P & Richard P Simmons Ctr Interstitial Lu, Div Pulm Allergy & Crit Care Med,McGowan Inst Reg, Pittsburgh, PA USA
[5] Univ Edinburgh, Queens Med Res Inst, Edinburgh, Midlothian, Scotland
[6] CIBERES, IDIBAPS, Barcelona, Spain
关键词
chronic obstructive pulmonary disease; fibrosis; interstitial lung disease; inflammation; repair; GLYCATION END-PRODUCTS; MESENCHYMAL STEM-CELLS; AGE-RELATED-CHANGES; NF-KAPPA-B; BONE-MARROW; OXIDATIVE STRESS; T-CELLS; CIRCULATING FIBROCYTES; TELOMERE LENGTH; DENDRITIC CELLS;
D O I
10.1164/rccm.201202-0282PP
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Aging is a natural process characterized by progressive functional impairment and reduced capacity to respond appropriately to environmental stimuli and injury. The incidence of two common chronic respiratory diseases (chronic obstructive pulmonary disease [COPD] and idiopathic pulmonary fibrosis [IPF]) increases with advanced age. It is plausible, therefore, that abnormal regulation of the mechanisms of normal aging may contribute to the pathobiology of both COPD and IPF. This review discusses the available evidence supporting a number of aging mechanisms, including oxidative stress, telomere length regulation, cellular and immunosenescence, as well as changes in a number of antiaging molecules and the extracellular matrix, which are abnormal in COPD and/or IPF. A better understanding of these abnormalities may help in the design of novel and better therapeutic interventions for these patients.
引用
收藏
页码:306 / 313
页数:8
相关论文
共 50 条
  • [1] Pulmonary hypertension associated with chronic obstructive lung disease and idiopathic pulmonary fibrosis
    Adir, Yochai
    Harari, Sergio
    CURRENT OPINION IN PULMONARY MEDICINE, 2014, 20 (05) : 414 - 420
  • [2] Why Does an Aging Smoker's Lung Develop Idiopathic Pulmonary Fibrosis and Not Chronic Obstructive Pulmonary Disease?
    Selman, Moises
    Martinez, Fernando J.
    Pardo, Annie
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199 (03) : 279 - 285
  • [3] CHRONIC OBSTRUCTIVE PULMONARY-DISEASE FOLLOWING IDIOPATHIC PULMONARY FIBROSIS
    MCCARTHY, DS
    OSTROW, DN
    HERSHFIELD, ES
    CHEST, 1980, 77 (04) : 473 - 477
  • [4] CHRONIC PULMONARY-DISEASES - CHRONIC OBSTRUCTIVE PULMONARY-DISEASE AND IDIOPATHIC PULMONARY FIBROSIS
    AGUSTI, AGN
    BARBERA, JA
    THORAX, 1994, 49 (09) : 924 - 932
  • [5] Differences in Response to Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease
    Kozu, Ryo
    Senjyu, Hideaki
    Jenkins, Sue C.
    Mukae, Hiroshi
    Sakamoto, Noriho
    Kohno, Shigeru
    RESPIRATION, 2011, 81 (03) : 196 - 205
  • [6] PULMONARY REHABILITATION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS: COMPARISON WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Arizono, Shinichi
    Taniguchi, Hiroyuki
    Sakamoto, Koji
    Kondoh, Yasuhiro
    Kimura, Tomoki
    Kataoka, Kensuke
    Ogawa, Tomoya
    Watanabe, Fumiko
    Tabira, Kazuyuki
    Kozu, Ryo
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2017, 34 (04) : 283 - 289
  • [7] Quantitative proteomic characterization of the lung extracellular matrix in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis
    Ahrman, Emma
    Hallgren, Oskar
    Malmstrom, Lars
    Hedstrom, Ulf
    Malmstrom, Anders
    Bjermer, Leif
    Zhou, Xiao-Hong
    Westergren-Thorsson, Gunilla
    Malmstrom, Johan
    JOURNAL OF PROTEOMICS, 2018, 189 : 23 - 33
  • [8] The Aging Lung and Idiopathic Pulmonary Fibrosis
    Gulati, Swati
    Thannickal, Victor J.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2019, 357 (05): : 384 - 389
  • [9] THE BURDEN OF COMORBIDITY IN IDIOPATHIC PULMONARY FIBROSIS VERSUS CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Chapman, R.
    Ozaltin, B.
    Direk, K.
    Jacob, J.
    THORAX, 2023, 78 (SUPPL_4) : A10 - A11
  • [10] Innate immunity proteins in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis
    Tsoumakidou, Maria
    Bouloukaki, Izolde
    Thimaki, Katerina
    Tzanakis, Nikos
    Siafakas, Nikos M.
    EXPERIMENTAL LUNG RESEARCH, 2010, 36 (06) : 373 - 380